Back to Authors

Yang, Keri

A5124453869 | I4405263195

Mayo Clinic

BeOne Medicines (Switzerland)

Citations 2

Real-world treatment utilization patterns, discontinuation and healthcare resource utilization of first-line Bruton tyrosine kinase inhibitors among elderly patients ≥65 years in chronic lymphocytic leukemia

Expert Review of Hematology | February 10, 2026 | Volume: 19 | Issue: 5 | Pages: 539-546

10.1080/17474086.2026.2628534 | PMID 41666415

Number needed to treat to avoid progression and death and cost analysis: zanubrutinib versus acalabrutinib in relapsed/refractory chronic lymphocytic leukemia

Future Oncology | January 31, 2026 | Volume: 22 | Issue: 3 | Pages: 339-348

10.1080/14796694.2026.2615736 | PMID 41618895